SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-011952
Filing Date
2019-08-09
Accepted
2019-08-09 08:01:23
Documents
67
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 504086
2 ex31-1.htm EX-31.1 11724
3 ex31-2.htm EX-31.2 11724
4 ex32-1.htm EX-32.1 10462
  Complete submission text file 0001493152-19-011952.txt   4022228

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE cocp-20190630.xml EX-101.INS 772855
6 XBRL SCHEMA FILE cocp-20190630.xsd EX-101.SCH 45901
7 XBRL CALCULATION FILE cocp-20190630_cal.xml EX-101.CAL 59587
8 XBRL DEFINITION FILE cocp-20190630_def.xml EX-101.DEF 203606
9 XBRL LABEL FILE cocp-20190630_lab.xml EX-101.LAB 342478
10 XBRL PRESENTATION FILE cocp-20190630_pre.xml EX-101.PRE 281670
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 191011350
SIC: 2834 Pharmaceutical Preparations